FILANA THERAPEUTICS, INC. - 8-K Filing
Filana Therapeutics appoints biopharma executive Jill M. Quigley to Board of Directors as Class I Director. (Items: 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), 9.01 Financial Statements and Exhibits)
Tickers: $SAVA